Plunkett Research Online: Athersys Inc

ATHERSYS INC (ATHX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Athersys Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates. The company’s current product development portfolio consists of MultiStem, a patented and proprietary stem cell product that it is developing as a treatment for multiple disease .....



Athersys Inc
Ticker: ATHX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 216 431-9900
Fax: 216 361-9495
Address: 3201 Carnegie Avenue
Cleveland, OH 44115-2634 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Gil Van BokkelenCEO/Chairman of the Board/Co-Founder/Director
Laura CampbellCFO/Chief Accounting Officer/Senior VP, Divisional
See More
Athersys Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates. The company’s current product development portfolio consists of MultiStem, a patented and proprietary stem cell product that it is developing as a treatment for multiple disease .....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Jones Day
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: